Best GLP-1 tablets and lozenges, ranked on care
Only sellers that price a GLP-1 you do not inject, each ranked on that product rather than on its injection, which is priced and studied differently.
Disclosure: This Peptide is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
6 sellers are partners on this board today, sorted first and labeled Partner — the one respect in which the ordering is commercial. Every other seller here is ranked purely on the published rubric, which cannot see commercial status either way.
The board at a glance
- 6 sellers are on the GLP-1 tablet and lozenge board; 3 of them name their compounding pharmacy, and 1 requires a consultation before any prescription.
- The lowest monthly figure published in this board's scope is $99/mo, for Semaglutide sublingual at Strut Health; price is 6% of the order here, so it does not decide the rank.
- 0 of the 6 price semaglutide and tirzepatide in both forms, so you can compare the two at one seller.
What the evidence says, before the sellers
- SemaglutideFDA-approved
Large trials for weight. 1 randomized trial of 1,000 or more people cited here for weight.
Every trial above used the approved product at labeled doses. None tested a compounded preparation, so their results describe Wegovy, not what a compounding pharmacy makes.
- TirzepatideFDA-approved
Large trials for weight. 1 randomized trial of 1,000 or more people cited here for weight.
Both trials used the approved product. Neither tested a compounded preparation, so the numbers describe Zepbound, not a pharmacy's version of it.
The ranking
Each seller below prescribes semaglutide and tirzepatide as a oral and a sublingual and has a full review on this site; each block reads its care mark by mark, in the words its own pages support.
- Rank01
Synergy RxPartner
Synergy Rx is first on the GLP-1 tablet and lozenge board, carried by its prescriber and intake mark and its pharmacy named mark; its weakest mark here is price against the market.
Synergy Rx's own spread between forms: Semaglutide oral from $299/mo against injection from $199/mo and Tirzepatide oral from $399/mo against injection from $349/mo.
- What it prices here
- Semaglutide oral (compounded)from $299/mo
- Tirzepatide oral (compounded)from $399/mo
- Prescriber and intake
- Names its prescribing doctors; a consultation before any prescription
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Semaglutide: schedule printed, no strength; Tirzepatide: schedule printed, no strength
- Follow-up
- Scheduled check-ins, with messaging
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- All 50 states
- Price against the market
- Above the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the GLP-1 tablet and lozenge board Synergy Rx is read on 80% of the rubric's weight: price as the dose rises is left out of its order, not counted against it.
- Rank02
OakPartner
Oak is second on the GLP-1 tablet and lozenge board, carried by its pharmacy named mark and its stays within legal scope mark; its weakest mark here is dosing guidance.
Oak prices semaglutide only as oral and sublingual among the rows we hold, so there is no other form of it to set beside this one.
- What it prices here
Semaglutide is on Oak's own list with no price we hold.
- Prescriber and intake
- Names no prescriber; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Semaglutide: no dose printed
- Follow-up
- Not recorded: our review found no answer on its pages
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Not recorded: no monthly price in this scope
- Price as the dose rises
- Price rises with the dose
On the GLP-1 tablet and lozenge board Oak is read on 65% of the rubric's weight: follow-up, state coverage and price against the market are left out of its order, not counted against it.
- Rank03
Breeze MedsPartner
Breeze Meds is third on the GLP-1 tablet and lozenge board, carried by its pharmacy named mark and its stays within legal scope mark; its weakest mark here is dosing guidance.
Breeze Meds's own spread between forms: Semaglutide oral from $299/mo against injection from $199/mo.
- What it prices here
- Semaglutide oral (compounded)from $299/mo
- Tirzepatide oral (compounded)from $399/mo
- Prescriber and intake
- Names its prescribing doctors; a questionnaire, with no live visit mentioned
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Semaglutide: no dose printed; Tirzepatide: no dose printed
- Follow-up
- Not recorded: our review found no answer on its pages
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- All 50 states
- Price against the market
- Above the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the GLP-1 tablet and lozenge board Breeze Meds is read on 70% of the rubric's weight: follow-up and price as the dose rises are left out of its order, not counted against it.
- Rank04
Direct MedsPartner
Direct Meds is fourth on the GLP-1 tablet and lozenge board; its weakest mark here is prescriber and intake.
Direct Meds's own spread between forms: Semaglutide sublingual from $249/mo against injection from $297/mo and Tirzepatide sublingual from $299/mo against injection from $399/mo.
- What it prices here
- Semaglutide sublingual (compounded)from $249/mo
- Tirzepatide sublingual (compounded)from $299/mo
- Prescriber and intake
- Names no prescriber
- Pharmacy named
- Not recorded: our review found no answer on its pages
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Not recorded: our review found no answer on its pages
- Stays within legal scope
- Also lists BPC-157, which no pharmacy may lawfully compound
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Above the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the GLP-1 tablet and lozenge board Direct Meds is read on 40% of the rubric's weight: pharmacy named, dosing guidance, follow-up, state coverage and price as the dose rises are left out of its order, not counted against it.
- Rank05
Strut HealthPartner
Strut Health is fifth on the GLP-1 tablet and lozenge board, carried by its stays within legal scope mark and its follow-up mark; its weakest mark here is pharmacy named.
Strut Health's own spread between forms: Semaglutide sublingual from $99/mo against injection from $149/mo and Tirzepatide sublingual from $199/mo against injection from $149/mo.
- What it prices here
- Semaglutide sublingual (compounded)from $99/mo
- Tirzepatide sublingual (compounded)from $199/mo
- Prescriber and intake
- Names one prescribing physician; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Semaglutide: no dose printed; Tirzepatide: no dose printed
- Follow-up
- Unlimited follow-ups, free
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- 49 states
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the GLP-1 tablet and lozenge board Strut Health is read on 80% of the rubric's weight: price as the dose rises is left out of its order, not counted against it.
- Rank06
MangoRxPartner
MangoRx is sixth on the GLP-1 tablet and lozenge board, carried by its prescriber and intake mark and its follow-up mark; its weakest mark here is pharmacy named.
MangoRx prices semaglutide only as oral and sublingual among the rows we hold, so there is no other form of it to set beside this one.
- What it prices here
- Semaglutide sublingual (compounded)from $299/mo
- Prescriber and intake
- Names its physician network
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Scheduled check-ins, with messaging
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Above the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the GLP-1 tablet and lozenge board MangoRx is read on 65% of the rubric's weight: dosing guidance, state coverage and price as the dose rises are left out of its order, not counted against it.
What the order on this board weighs
On the GLP-1 tablet and lozenge board 8 of the rubric's 9 marks apply, rescaled to share the whole order between them: prescriber and intake carries 29%, pharmacy named carries 18% and dosing guidance carries 12%. What each mark reads
- 29%
- Prescriber and intake
- 18%
- Pharmacy named
- 12%
- Dosing guidance
- 12%
- Follow-up
- 12%
- Stays within legal scope
- 6%
- State coverage
- 6%
- Price against the market
- 6%
- Price as the dose rises
Whether a seller pays us is not one of the 8 marks on the GLP-1 tablet and lozenge board, and the rubric cannot read it.
Best GLP-1 tablets and lozenges, ranked on care
Frequently asked questions
- How is the GLP-1 tablet and lozenge board ordered?
- The 6 partners sort first and are labeled; after that the rubric decides. The rubric reads each seller on semaglutide and tirzepatide as a oral and a sublingual, and here prescriber and intake carries 29%, pharmacy named carries 18% and dosing guidance carries 12%.
- Do you earn a commission from the sellers on the GLP-1 tablet and lozenge board?
- On part of it. 6 sellers are partners on the GLP-1 tablet and lozenge board, labeled Partner where they appear; the rest of the links pay us nothing.
- Which marks are not recorded on the GLP-1 tablet and lozenge board?
- Not recorded: price as the dose rises for Synergy Rx, follow-up, state coverage and price against the market for Oak, follow-up and price as the dose rises for Breeze Meds, pharmacy named, dosing guidance, follow-up, state coverage and price as the dose rises for Direct Meds, price as the dose rises for Strut Health and dosing guidance, state coverage and price as the dose rises for MangoRx. Each is left out of that seller's order on this board, because our review of its pages found no answer, and the seller's other marks carry its place instead.
- Which sellers of semaglutide and tirzepatide are not on this board?
- 82 more sellers on our roster publish a price for semaglutide and tirzepatide as a oral and a sublingual and are not ranked on the GLP-1 tablet and lozenge board until we publish a review of each one.